Abstract

Doc number: O56

Details

Title
Phase 2a safety and immunogenicity testing of DNA and recombinant modified vaccinia ankara virus vaccines expressing virus-like particles
Author
Goepfert, P; Elizaga, M; Montefiori, D; Hural, J; DeRosa, S; Tomaras, G; Seaton, K; Sato, A; Ouedraogo, L; Donastorg, Y; Cardinali, M; Lama, J; Baden, L; Keefer, M; McElrath, J; Kalams, S; Robinson, H
Publication year
2012
Publication date
2012
Publisher
BioMed Central
e-ISSN
17424690
Source type
Scholarly Journal
Language of publication
English
DOI
https://doi.org/10.1186/1742-4690-9-S2-O56
ProQuest document ID
1039222367
Copyright
© 2012 Goepfert et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.